COMPANY

Blaze Bioscience Inc.

HQ: Seattle, WA source · blazebioscience.com ↗ · West Coast

Also known as Blaze Bioscience · 7 sources

Location: Seattle, WA · source · Oct 21, 2024

Profile checked Oct 10, 2026

Keywords: Pediatric Central Nervous System Tumor Central Nervous System Tumors Breast Tumors Soft Tissue Sarcoma Glioma sarcoma BLZ-100 Tozuleristide

Timeline

Nov 26, 2018 Trial start Phase 2/Phase 3: Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery source ↗
2015-09 Trial start Phase 1: Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery source ↗
2015-07 Trial start Phase 1: Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery source ↗
2015-06 Trial start Phase 1: Study of BLZ-100 in Pediatric Subjects With CNS Tumors source ↗
2014-10 Trial start Phase 1: Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT04343274	Expanded Access for BLZ-100 (Tozuleristide)	Not listed	No longer available	Not listed	Not listed
NCT03579602	Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery	Phase 2/Phase 3	Completed	Nov 26, 2018	Apr 1, 2022 (actual)
NCT02462629	Study of BLZ-100 in Pediatric Subjects With CNS Tumors	Phase 1	Completed	2015-06	2018-07 (actual)
NCT02496065	Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery	Phase 1	Completed	2015-07	2016-12 (actual)
NCT02464332	Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery	Phase 1	Withdrawn	2015-09	2016-05 (actual)
NCT02234297	Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery	Phase 1	Completed	2014-10	2016-02 (actual)

Annual award amounts. Total $1.7M.

2014 NIH contract (government contract; not a grant and not an investment round) 261201400046C-0-0-1 FY2014: $1,499,549 awarded for that fiscal year; activity N44 (OTHER_NIH); PI MILLER, DENNIS; recipient as written: BLAZE BIOSCIENCE, INC., SEATTLE, WA. IGF::OT::IG source ↗
2012 NIH contract (government contract; not a grant and not an investment round) 261201200054C-0-0-1 FY2012: $248,551 awarded for that fiscal year; activity N43 (OTHER_NIH); PI PARRISH NOVAK, JULIA; recipient as written: BLAZE BIOSCIENCE, INC., SEATTLE, WA. OTHER F source ↗